← Open Payments lookup

BERNARD MICHLIN: Open Payments

NPI 1861492738 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,911 in 184 payments from 40 companies in 2025. Trend: 2023 $6,090 · 2024 $4,781 · 2025 $3,911

Food & beverage: $3,869Education: $43
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.16$534
UCB, Inc.22$309
Neurocrine BioSciences, Inc.7$261
ABBVIE INC.14$234
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$216
Bayer Healthcare Pharmaceuticals Inc.7$205
Axsome Therapeutics, Inc.4$193
PFIZER INC.14$145
AstraZeneca Pharmaceuticals LP8$143
Neurelis, Inc.16$140

Products named: FANAPT, INGREZZA, CAPLYTA, Kerendia, Auvelity, VRAYLAR, Fintepla, VALTOCO.

Industry payments across CA — which companies pay providers there.